Información del artículo
El Texto completo está disponible en PDF
Bibliografía general
[Abosch et al., 1998]
A. Abosch, J.B. Tyrrell, K.R. Lamborn, L.T. Hannegan, C.B. Applebury, C.B. Wilson.
Transsphenoidal microsurgery for growth hormone- secreting pituitary adenomas: inicial outcome and longterm results.
J Clin Endocrinol Metab, 83 (1998), pp. 3411-3418
[Beauregard et al., 2003]
C. Beauregard, U. Truong, J. Hardy, O. Serri.
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.
Clin Endocrinol (Oxf), 58 (2003), pp. 86-91
[Consensus, 2004]
Consensus Statement. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. J Clin Endocrinol Metab. 2004; 89: 3099-102.
[De et al., 2003]
P. De, D.A. Rees, N. Davies, R. John, J. Neal, R.G. Mills, et al.
Transsphenoidal surgery for acromegaly in Wales: results based on stringent criteria of remission.
J Clin Endocrinol Metab, 88 (2003), pp. 3567-3572
[Dimaraki et al., 2002]
E.V. Dimaraki, C.A. Jaffe, R. DeMott-Friberg, W.F. Chandler, A.L. Barkan.
Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
J Clin Endocrinol Metab, 87 (2002), pp. 3537-3542
[Freda et al., 2004]
P.U. Freda, A.T. Nuruzzaman, C.M. Reyes, R.E. Sundeen, K.D. Post.
Significance of “abnormal” nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
J Clin Endocrinol Metab, 89 (2004), pp. 495-500
[Freda et al., 1998a]
P.U. Freda, K.D. Post, J.S. Powell, S.L. Wardlaw.
Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
J Clin Endocrinol Metab, 83 (1998), pp. 3808-3816
[Freda et al., 1998b]
P.U. Freda, S.L. Wardlaw, K.D. Post.
Long-term endocrinological follow- up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
J Neurosurg, 89 (1998), pp. 353-358
[Giustina et al., 2000]
A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, et al.
S. Consensus. Criteria for cure of acromegaly: a consensus statement.
J Clin Endocrinol Metab, 85 (2000), pp. 526-529
[Holdaway et al., 2004]
I.M. Holdaway, R.C. Rajasoorya, G.D. Gamble.
Factors influencing mortality in acromegaly.
J Clin Endocrinol Metab, 89 (2004), pp. 667-674
[Krieger et al., 2003]
M.D. Krieger, W.T. Couldwell, M.H. Weiss.
Assessment of long-term remission of acromegaly following surgery.
J Neurosug, 98 (2003), pp. 719-724
[Orme et al., 1998]
S.M. Orme, R.J.Q. Mcnally, R.A. Cartwright, P.E. Belchetz.
Mortality and cancer incidence in acromegaly: a retrospective cohort study.
J Clin Endocrinol Metab, 83 (1998), pp. 2730-2734
[Swearingen et al., 1998]
B. Swearingen, G F Barker II, L. Katznelson, B.M.K. Biller, S. Grinsspoon, A. Klibanski, et al.
Long-term mortality after transsphenoidal surgery and adjuntive therapy for acromegaly.
J Clin Endocrinol Metab, 83 (1998), pp. 3419-3426
Miembros del Grupo de Trabajo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición: C. Villabona (coordinador), M. Català, T. Lucas, B. Moreno, G. Obiols, C. Páramo, A. Picó, E. Torres, C. Varela, B. Zugasti, S. Webb, I. Halperin y L. Castaño.
Copyright © 2005. Sociedad Española de Endocrinología y Nutrición
